How Minor Cannabinoids are Made: Synthetic vs Biosynthetic ft. Shane Johnson

Synthesis, a process that may sound complex, is actually quite common in our daily lives. From the production of everyday items like Advil, organic milk, citric acid, to the creation of vitamins A and D, and multivitamins, synthesis is a key player. Why does this realization often provoke a negative reaction? Perhaps it's because there's a desire for clean, safe, and consistent natural products, especially when they originate from plants. Surprisingly, synthesis enhances our ability to deliver such products. This week, we're joined by Shane Johnson to delve into the following topics: • How minors are manufactured, synthetic vs. biosynthetic • Upcoming Minors to keep an eye on • Novel APIs & Analogs 00:00  Special Guest Shane Johnson on Dimes Podcast with Brian Fields and Kellan Finney 00:06  Exploring the Future of Manufacturing with Shane Johnson from BayMedica 03:07  Revolutionizing Medicine: The Impact of Modern Cannabinoid Manufacturing on Healthcare 07:11  The Future of Cannabinoid Manufacturing and Regulation in the Medical Industry 10:57  Unlocking the Potential of Synthesizing Plant Chemicals for Therapeutic Benefits 14:42  Creating Stability in Cannabinoid Production: The Key to Consistent Consumer Experience 24:31  Unraveling the Complexities of Cannabinoids and Personal Physiology in Research 28:23  Unveiling the Future of Western Medicine: A Focus on Pure Compounds and Cannabinoids 32:02  Exploring the Use of Cannabinoids as Diluents in Vape Products and Pharmaceutical Development 35:47  Uncovering Exciting Minor Cannabinoids: CBC and THCV 40:09  Innovative Manufacturing and Research in Cannabinoids Industry 45:30  The Cost of Cannabinoids: Lessons in Market Dynamics and Pricing 49:05  Unlocking Personalized Cannabinoid Formulations: A Future Dream in Pharmaceutical Industry About Dr. Shane Johnson Dr. Shane Johnson’s career has focused principally on offering strategic business advisory services to companies in the biotechnology and healthcare sectors. His work has included guiding regulatory strategy, product portfolio assessment and valuations, and product development and launch strategies for companies including Biogen Idec, Amgen, and Genentech. Shane was a Principal at Hamilton BioVentures (a Life Science venture capital firm), an Engagement Manager at L.E.K. Consulting (an international strategy consulting firm), and held operational roles in several early stage companies. For the past 4 years, Shane’s work has been focused on the cannabis and cannabinoid science space, and he has developed a strong working knowledge of clinical opportunities in the sector. He is currently on the Board of Directors of several cannabis-related companies, and is a co-founder of one of Nevada’s leading cultivators and producers of premium cannabis products including a patented lozenge. Shane holds a B.A. in Studio Art and a B.S. in Neuroscience (with honors) from Brown University, an M.D. from the Stanford University School of Medicine, and is a Fulbright Scholar. Guest Links https://www.baymedica.com/ https://www.linkedin.com/in/shanejohnson3/ https://www.youtube.com/channel/UC-XRZ0FMzcWgFL_mqdAOPRw https://twitter.com/BayMedica Follow us: Our Links. At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry. 8th Revolution Cannabinoid Playbook is an Industry-leading report covering the entire cannabis supply chain The Dime is a top 5% most shared global podcast The Dime is a top 50 Cannabis Podcast Sign up for our playbook here: https://www.8threv.com/monthly-report/ 🎥 YouTube: The Dime 📸 Instagram: The Dime Twitter : https://twitter.com/TheDime\_8th https://twitter.com/bryanfields24 https://twitter.com/kellan\_Finney